Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | NDAQ

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
GENFLOW BIOSCIENCES PLC Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.	United Kingdom	GENF
GENINUS Inc. AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.	South Korea	389030
genOway Develops custom genetically modified preclinical models for biopharma and academic research.	France	ALGEN
Genpact LTD Drives business transformation for enterprises using AI, data, and technology services.	United States of America	G
GenSight Biologics S.A. Developing gene therapies for neurodegenerative diseases of the eye and central nervous system.	France	SIGHT
GeoVax Labs, Inc. Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.	United States of America	GOVX
GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. A travel agency offering online booking for transport, hotels, cultural tours, and cruises.	Türkiye	GZNMI
GIG Works Inc. Connects businesses with gig workers, offering staffing, BPO, IT, and coworking services in Japan.	Japan	2375
Globe Capital Limited An investment company providing global marketing and promotion services, focusing on UK businesses.	Cayman Islands	GCAP
GMO Research & AI, Inc. Market research tech providing access to 65M+ APAC consumer panelists for data-driven insights.	Japan	3695